Quadrant

Quadrant Biosciences is a life science company specializing in the development of epigenetic diagnostic tools for complex health conditions. The company's core technology platform, Clarifi, leverages RNA expression analysis from saliva samples to provide objective clinical insights. Their flagship product, Clarifi ASD, is the first epigenetic saliva test designed to assist in the early diagnosis of autism spectrum disorder. Beyond pediatrics, Quadrant is expanding its diagnostic pipeline to address mild traumatic brain injury and neurodegenerative diseases like Parkinson's. The company also played a significant role in public health by developing high-sensitivity saliva-based COVID-19 testing solutions. Headquartered in Syracuse, New York, Quadrant maintains deep research collaborations with SUNY Upstate Medical University and Penn State.